Rankings
▼
Calendar
GERN Q4 2025 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena
GERN
Geron Corporation
$1B
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$48M
+1.0% YoY
Gross Profit
$47M
97.3% margin
Operating Income
-$11M
-22.5% margin
Net Income
-$31M
-64.9% margin
EPS (Diluted)
$-0.05
QoQ Revenue Growth
+1.7%
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$22M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$571M
Total Liabilities
$347M
Stockholders' Equity
$224M
Cash & Equivalents
$79M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$48M
$48M
+1.0%
Gross Profit
$47M
$47M
-0.1%
Operating Income
-$11M
-$20M
+46.2%
Net Income
-$31M
-$25M
-22.8%
Revenue Segments
Revenues Before Adjustments
$60M
55%
Product
$48M
45%
Government Rebates
$65,000
0%
← FY 2025
All Quarters